USFDA Inspection at Alembic Pharma's API facility at Karkhadi

This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations, the company said.

Jan 21, 2020 03:01 IST India Infoline News Service

Alembic Pharmaceuticals
The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from January 13-17, 2020.

This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations.

Stock view:
On Monday’s trade, Alembic Pharmaceuticals Ltd ended at Rs600, up by Rs1.25 or 0.21% from its previous closing of Rs598.75 on the BSE.

The scrip opened at Rs600 and touched a high and low of Rs600 and Rs600 respectively.

Related Story